| Product NDC: | 52584-469 |
| Proprietary Name: | Naloxone Hydrochloride |
| Non Proprietary Name: | Naloxone Hydrochloride |
| Active Ingredient(s): | 1 mg/mL & nbsp; Naloxone Hydrochloride |
| Administration Route(s): | PARENTERAL |
| Dosage Form(s): | INJECTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 52584-469 |
| Labeler Name: | General Injectables & Vaccines, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA072076 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20101227 |
| Package NDC: | 52584-469-00 |
| Package Description: | 1 BOX in 1 BAG (52584-469-00) > 1 SYRINGE in 1 BOX > 2 mL in 1 SYRINGE |
| NDC Code | 52584-469-00 |
| Proprietary Name | Naloxone Hydrochloride |
| Package Description | 1 BOX in 1 BAG (52584-469-00) > 1 SYRINGE in 1 BOX > 2 mL in 1 SYRINGE |
| Product NDC | 52584-469 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Naloxone Hydrochloride |
| Dosage Form Name | INJECTION |
| Route Name | PARENTERAL |
| Start Marketing Date | 20101227 |
| Marketing Category Name | ANDA |
| Labeler Name | General Injectables & Vaccines, Inc. |
| Substance Name | NALOXONE HYDROCHLORIDE |
| Strength Number | 1 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Opioid Antagonist [EPC],Opioid Antagonists [MoA] |